Pure high anion gap metabolic acidosis critical pathways: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) No edit summary |
m (Bot: Removing from Primary care) |
||
| (2 intermediate revisions by one other user not shown) | |||
| Line 12: | Line 12: | ||
{|CELLPADDING=20 STYLE="WIDTH:50%; HEIGHT:50px" BORDER="1" | {|CELLPADDING=20 STYLE="WIDTH:50%; HEIGHT:50px" BORDER="1" | ||
| BGCOLOR=FLORALWHITE STYLE="WIDTH:50%"| Delta-delta (ΔΔ) value || BGCOLOR=LIGHTGRAY STYLE="WIDTH:16.6%" | [[High anion gap metabolic acidosis with metabolic alkalosis critical pathways|Greater than 2]] || BGCOLOR=MEDIUMAQUAMARINE STYLE="WIDTH:16.6%" | [[Pure high anion gap metabolic acidosis critical pathways|Between 1 and 2]] || BGCOLOR=LIGHTGRAY STYLE="WIDTH:16.6%" | [[High anion gap metabolic acidosis with normal anion gap metabolic | | BGCOLOR=FLORALWHITE STYLE="WIDTH:50%"| Delta-delta (ΔΔ) value || BGCOLOR=LIGHTGRAY STYLE="WIDTH:16.6%" | [[High anion gap metabolic acidosis with metabolic alkalosis critical pathways|Greater than 2]] || BGCOLOR=MEDIUMAQUAMARINE STYLE="WIDTH:16.6%" | [[Pure high anion gap metabolic acidosis critical pathways|Between 1 and 2]] || BGCOLOR=LIGHTGRAY STYLE="WIDTH:16.6%" | [[High anion gap metabolic acidosis with normal anion gap metabolic acidosis critical pathways|Less than 1]] | ||
|} | |} | ||
| Line 19: | Line 19: | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WikiDoc Help Menu}} | |||
{{WikiDoc Sources}} | |||
[[Category:Critical pathways]] | [[Category:Critical pathways]] | ||
| Line 24: | Line 26: | ||
[[Category:Medicine]] | [[Category:Medicine]] | ||
[[Category:Nephrology]] | [[Category:Nephrology]] | ||
Latest revision as of 23:54, 29 July 2020
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Approach
| metabolic acidosis critical pathways |
| Anion gap | High | Normal | Low |
| Delta-delta (ΔΔ) value | Greater than 2 | Between 1 and 2 | Less than 1 |